PNV 3.29% $2.35 polynovo limited

Paul Brennan Interview, page-22

  1. 964 Posts.
    lightbulb Created with Sketch. 23
    I am happy because you don’t get an opportunity too many times to buy into a company with FDA approvals, large market opp, all the risk taken out of it for a few hundred mill market cap.

    There are many companies out there with hype worth more than this company’s market cap
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.